The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Abstract

Objective:

Discordance between psychiatric care providers’ and clients’ goals for medication treatment is prevalent and is a barrier to person-centered care. Power statements—short self-advocacy statements prepared by clients in response to a two-part template—offer a novel approach to help clients clarify and communicate their personal goals for using psychiatric medications. This study described the power statement method and examined a sample of power statements to understand clients’ goals for medication treatment.

Methods:

More than 17,000 adults with serious mental illness at 69 public mental health clinics had the option to develop power statements by using a Web application located in the clinic waiting areas. A database query determined the percentage of clients who entered power statements into the Web application. The authors examined textual data from a random sample of 300 power statements by using content analysis.

Results:

Nearly 14,000 (79%) clients developed power statements. Of the 277 statements in the sample deemed appropriate for content analysis, 272 statements had responses to the first part of the template and 230 had responses to the second part. Clients wanted psychiatric medications to help control symptoms in the service of improving functioning. Common goals for taking psychiatric medications (N=230 statements) were to enhance relationships (51%), well-being (32%), self-sufficiency (23%), employment (19%), hobbies (15%), and self-improvement (10%).

Conclusions:

People with serious mental illness typically viewed medications as a means to pursue meaningful life goals. Power statements appear to be a simple and scalable technique to enhance clients’ communication of their goals for psychiatric medication treatment.

Clients with serious mental illness are often passive in their interactions with professionals, even though they frequently disagree with their providers regarding treatment goals (14). Enhancing communication therefore necessitates client activation, which can improve person-centered care (5), including shared decision making (6), satisfaction with process (7), and outcomes (8).

Psychotropic medications often support clients’ recovery (9), yet prescribing in routine practice often falls short of person-centered care (10,11). Psychiatric care providers often evaluate symptoms and side effects without inquiring about the context of personal goals, values, and preference (12). Evaluating symptoms and side effects out of the context of clients’ lives and life goals can result in an emphasis on symptom relief and medication adherence as endpoints, rather than as a means to achieve clients’ goals for treatment (13,14). Time constraints have further jeopardized communication and are unlikely to expand (15). Thus, approaches that facilitate communication and person-centered care in routine practice without requiring more time, such as using aids to help clients communicate their goals for medication prior to the consultation, are critically needed.

Power statements are a novel approach that enables clients to communicate their goals for medication treatment by preparing clear and concise statements prior to a medication visit (16). The purpose of this exploratory study is to describe the power statement method and analyze the content of these statements thematically to understand clients’ goals for using psychiatric medications.

Methods

Power statements are part of CommonGround, a Web application that enables people with serious mental illness to participate in shared decision making and supports their recovery (17). Peer staff, case managers, and therapists are trained to support clients in creating power statements in the waiting area of public mental health clinics by using a worksheet that guides users in filling out a two-part stem: “I want you to help me find a medication that will help me . . . so that I can. . . .” Completed power statements are added to the Web application and appear on the health report that is reviewed by psychiatric care providers at each visit. With support from peer staff, clients update their power statements prior to appointments as needed, for instance when clients’ goals for treatment have changed. Power statements—typically two or three sentences saying something about the client as a unique individual— state how she or he wants psychiatric medication to help and invite clinicians to help achieve these goals for medication treatment. These statements amplify the client’s voice and sense of control, while communicating concisely the client’s specific goals for using psychiatric medications. Toward the beginning of the appointment, psychiatric care providers often read the power statement aloud and ask, “Is this still the goal for our work together?” Clients and psychiatric care providers have reported that the process enhances communication (18).

Participants

A total of 17,385 clients with serious mental illness seen across 69 community mental health settings, including public mental health clinics (N=50) and assertive community treatment teams (N=19), around the United States were using the CommonGround Web application during the period of this study. Background data on a sample of 5,581 participating clients obtained from a convenience sample of 20 community mental health settings showed a range of demographic and clinical characteristics. On average, 2,991 (54%) of CommonGround users were female, 949 (17%) were Hispanic, 4,275 (77%) were European American, 832 (15%) were African American, and 474 (9%) were other race or multicultural. The mean±SD age was 40.9±13.2 years. Common diagnoses for CommonGround users were schizophrenia/schizoaffective disorder (N=1,808, 32%), major depressive disorder (N=1,630, 29%), bipolar disorder (N=525, 9%), and anxiety disorder (N=396, 7%). A total of 1,619 (29%) clients in the sample had co-occurring substance use disorder diagnoses. The Dartmouth College Committee for the Protection of Human Subjects approved this study.

Procedures

We randomly selected from the CommonGround database a sample of 300 power statements from unique clients for the period of January 2011 through October 2013 and redacted the statements by hand to remove any identifying information. We also queried the CommonGround database to determine the percentage of distinct users, across the 69 sites, who had entered a power statement into the Web application.

We used methods in content analysis for analyzing and interpreting textual data (19). Initially, three of the authors (PED, EC-S, and RED) independently reviewed random selections of the statements to inductively derive the categories for the codebook, meeting regularly to discuss and refine categories, and producing a draft codebook. These same three authors then independently rated random selections of power statements to test the comprehensiveness and usefulness of the draft codebook, discussed ratings and coding discrepancies, and iteratively refined the codebook by adding or collapsing codes, resulting in 15 codes.

We trained two research assistants to independently rate the power statements. The two raters proceeded with coding in a two-stage process. The raters could use up to five codes for each part of the two-part stem template for the power statements to provide a more fine-grained summary of the statements by using subcategories. For example, the raters were able to use multiple codes to describe the same part of a participant’s power statement in order to allow for multiple possible interpretations. The two raters proceeded with coding in a two-stage process. First, to establish rating reliability, the two raters coded 10% of the data (30 statements per rater). The reliability of ratings across raters was assessed by using Cronbach’s alpha (20) and Stata 12’s alpha procedure (21). We obtained a Cohen’s kappa statistic of .97, thereby demonstrating high interrater reliability. We resolved discrepancies between raters for the 10% sample through team discussions and consensus. Second, the two raters independently coded the remaining 270 power statements. Descriptive statistics were used to summarize the results of the qualitative coding process. The analysis included participants who completed either or both parts of the power statement stem template.

Results

Our CommonGround database query found that 13,734 (79%) of 17,385 distinct users across 69 sites had entered power statements into the Web application. We rated 277 of the original 300 randomly selected power statements. We deemed the remaining 23 statements not ratable because their content was unrelated to psychiatric medication use. Not all participants completed both portions of the template; there were 272 responses to the first stem and 230 responses to the second stem. Of the 272 statements with ratings for the first stem, 150 (55%) received one code, 110 (40%) received two, 11 (4%) received three, and one (<1%) received four. Of the 230 statements with ratings for the second stem, 114 (50%) received one code, 81 (35%) received two, 26 (11%) received three, seven (3%) received four, and two (1%) received five.

Table 1 presents the distribution of goals for using psychiatric medications. In completing the first stem, clients most commonly identified wanting psychiatric treatment to help control symptoms (56%) and improve functioning (54%). For example, a client who wanted help controlling symptoms wrote: “I would like to work with the doctor to control my issues with anxiety and depression.” A client who was interested in improving functioning wrote: “I would like my medications to help me maintain stability so that I can find a job or find better housing.”

TABLE 1. Goals for using psychiatric medications expressed in 277 power statements prepared by clients with serious mental illnessa

Power statement stem and category of responseN%
Stem 1: “I want you to help me find a medication that will help me…”
 Symptom control (for example, stabilize mood, reduce paranoia)15256
 Function (for example, improve sleep, help me relax)14654
 Adjust medications (for example, lower dosage, switch medication)8331
 Clinical relationship (for example, problem solving, work with provider)207
 Modify lifestyle (for example, help to quit smoking, exercise)62
Stem 2: “…so that I can …”
 Social relationships (for example, so I can make friends)11751
 Well-being (for example, so I can deal with life)7332
 Self-sufficiency (for example, so I can stay in my apartment)5423
 Work (for example, so I can find a job)4419
 Hobbies (for example, so I can play the piano)3515
 Self-improvement (for example, so I can continue in my recovery)2410
 School (for example, so I can go back to school)167
 Community participation (for example, so I can go to church)115
 Treatment participation (for example, so I can attend a day program)73
 Faith (for example, so I can have a relationship with God)63
 Physical health (for example, so I can improve my physical health)52

aNot all participants completed both sections of the power statement template (N=272, stem 1; N=230, stem 2).

TABLE 1. Goals for using psychiatric medications expressed in 277 power statements prepared by clients with serious mental illnessa

Enlarge table

Many clients (N=83, 31%) also expressed specific medication goals, such as lowering dosages or switching or stopping medications. For example, “I want to work together with you to find the least amount of medicines at the lowest dosage.”

In completing the second stem, clients expressed the reasons why their specific medication goals were important, that is, the broader reasons for participating in psychiatric treatment. More than one-half of the clients (51%) identified improving or maintaining social relationships as a goal for using medications, for example, “so I can function like a normal mother.”

Achieving or maintaining well-being was another commonly expressed goal for treatment (32%), for example, “so I can deal with life.”

Many clients also described self-sufficiency (23%), employment (19%), and engaging in hobbies (15%) as goals for treatment. Examples of statements in these categories include “so I can keep up with my responsibilities” (self-sufficiency),“so that I can continue to work” (work), and “I enjoy reading short stories” (hobbies).

Some clients (10%) expressed their desire for self-improvement by continuing to progress in their recovery as a goal of treatment. For example, one client wrote, “I have come a long way in my life (really progressed) and want to continue to do better.”

Examples of complete power statements with both parts of the stem template are listed in a box on page XXX. These examples reflect many of the common codes used during the content analysis.

Discussion

Power statements potentially provide a scalable intervention in routine community mental health care settings. By using a brief prompt and minimal assistance, nearly 14,000 (79%) clients across 69 programs developed statements regarding their personal goals for using medication. The majority identified symptom control in the service of specific functional goals. Clients expressed a range of goals, reflecting the importance of relationships with friends and family, personal well-being, maintaining self-sufficiency and independence, pursuing work or school, participating in hobbies and leisure activities, and engaging in self-improvement. There is overlap between psychiatric care providers and clients in wanting to focus on symptom control and medication adjustment. However, the area of novelty is that power statements help clients link these clinical goals with personal goals such as social relationships and employment.

When empowered to communicate, clients express diverse and very personal goals for using medication that extend beyond symptom management. For most, using medication to control symptoms was not an end in itself but a means to an end that includes improved relationships, work, and other aspects of a meaningful life in the community. As more health care providers move toward measurement of treatment outcomes to monitor response to care (14), client input on those outcomes is beneficial and may improve the process. Power statements potentially enable clients to communicate these goals clearly and concisely.

Anecdotally, we have found that psychiatric care providers have a range of responses to power statements. Some report that power statements are unnecessary because they have known their clients for a long time and already know the context of clients’ lives. Others report they are surprised at the new information power statements reveal about people they have worked with. One psychiatrist working on an assertive community treatment team gave a lecture on his use of CommonGround and had this to say about power statements: “Power statements are really important because they rapidly summarize the patient. They rapidly present specific, powerful, self-worded representations of self. The self-worded part of it is like an automatic trigger for the patient. (When read aloud) suddenly the patient says, ‘Yeah, that’s me. That’s exactly what I want to do. Doctor you really get me.’ And remember, this is happening on day one, not a year after I’ve known the patient.”

Power statements appear to allow efficiency in helping psychiatric care providers understand clients’ goals from the beginning of treatment without requiring longer visits (22). In turn, these goals help to define treatment success. For instance, if a young man’s power statement communicates that he wants medicine to help him focus on his work at a pizza shop, rather than on auditory hallucinations, the psychiatric care provider and client have a shared understanding that could help guide treatment. Reduction in auditory hallucinations is not the only outcome that matters.

Sample Power Statements Reflecting the Importance of Symptom Control, Functioning, Social Relationships, and Self-Sufficiencya

“I am proud of myself, especially for defeating alcoholism. I have come a long way in my life (really progressed) and want to continue to do better. Work with me to find a medicine to help me concentrate, focus, ignore voices, and manage my anger so I can work at my job, stay out the hospital, enjoy family or friends, and do my chores around the house.”

“I am a determined person who wants to still accomplish more goals in life. Work with me to help me to continue to be able to cope without the use of medications so I can continue to make accomplishments in my life, like going back to school, continuing to working, enjoying my family and friends, helping my children, and participating in my church.”

“I am a young man that likes skateboarding. Being able to go back to school is the most important thing to me. I want to work with the doctor to find a medicine that helps me focus and be less depressed so that I can go back to school and complete it.”

“Helping others and caring for my family is important to me, because it gives me a purpose. I want to work with you to find a medicine that will help me be less depressed, less anxious and worried about finances and family members, so that I can keep up with my responsibilities and maintain positive, healthy relationships with people.”

“My family, and especially my three daughters, are very important to me. My time spent with family and my daughters is essential to my happiness and overall well-being. However, when depressed, I tend to be isolative and withdrawn from others, and my family. I need medication that will keep me from becoming depressed and isolative, so that I can better enjoy my family relationships.”

a Statements include responses to both sections 1 and 2 of the power statement template.

Health care providers, including those in behavioral health, struggle to integrate the practice of person-centered care and shared decision making in routine clinical settings. Practicing person-centered care means that psychiatric care providers must learn to ask, “What matters to you?” as well as “What is the matter?” (23). In an interesting twist, power statements may empower clients to be change agents in helping to make person-centered care happen. Through power statements, clients proactively communicate “what matters to me” and invite psychiatric care providers to support personal goals.

Power statements are relatively simple to teach and deploy, but they are not simple psychologically. They can have a powerful effect on both the client and the psychiatric care provider. For the client, power statements teach a specific method for becoming active in care. A clinic that supports using power statements implicitly communicates to clients that they are important, that they are partners in care, and that supporting the achievement of personal life goals is the point of treatment. Power statements also remind the provider of this: in a power statement, clients explicitly invite psychiatric care providers to partner together in achieving personally meaningful goals. This overture from clients may set the psychiatric care provider in a more responsive and receptive state of mind.

All psychiatric service providers are trained in communication and the importance of creating a strong alliance with clients in order to get the best treatment outcomes. However, the demands of routine medication appointments—symptom and side effect checks, substance use screening, laboratory tests, and documentation—can compete with the priority for communication of even the best intentioned psychiatric service providers (15). Power statements can help by providing a standardized and reliable way of communicating that can be embedded in the care pathway. Power statements can be created with pen and paper and do not necessarily require the use of the full CommonGround Web application.

Several limitations to our study warrant mention. Clients in the current investigation were actively engaged in mental health services, and our results may not generalize to those who do not use services or are tenuously engaged. Clients were also engaged in using CommonGround, a larger process that provides structure and peer support, which may perhaps be necessary for the use of power statements. In addition, staff in mental health clinics that have adopted CommonGround may be predisposed to value clients’ perspectives and shared decision making to a greater extent than those in clinics that have not adopted this application. With regard to our study methods, our use of content analysis techniques for interpreting the meaning of power statements may not have fully captured the individual goals and intentions contained within each statement. Last, given the exploratory nature of the current study, it was not possible to determine whether use of power statements contributed to improvement in communication or outcomes among clients. Future large-scale controlled studies are necessary to assess whether power statements improve communication and shared decision making between clients and psychiatric care providers in community mental health settings, and whether power statements are associated with outcomes that are meaningful to clients, including improved community functioning and ability to pursue life goals and interests.

Conclusions

Clients with serious mental illness typically viewed psychiatric medications as a means to pursue meaningful life goals, including social relationships, independence, and fulfilling responsibilities associated with roles such as worker, student, and parent. Power statements appear to be a simple, scalable, and highly promising technique to enhance patients’ communication of their goals for medication treatment, thus affording new opportunities to further the achievement of person-centered care in routine clinical practice.

Dr. Deegan is with Pat Deegan Ph.D. & Associates, L.L.C., Byfield, Massachusetts (e-mail: ). Dr. Carpenter-Song is with the Department of Anthropology and Dr. Drake and Mr. Naslund are with the Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Hanover, New Hampshire. Dr. Luciano is with the Center for the Study of Aging and Human Development, Duke University, Durham, North Carolina. Ms. Hutchison is with the Community Care Behavioral Health Organization, Pittsburgh.

Dr. Deegan receives financial benefit from the CommonGround software mentioned in the article. The other authors report no financial relationships with commercial interests.

References

1 Dimsdale JE, Klerman G, Shershow JC: Conflict in treatment goals between patients and staff. Social Psychiatry and Psychiatric Epidemiology 14:1–4, 1979Google Scholar

2 Fischer EP, Shumway M, Owen RR: Priorities of consumers, providers, and family members in the treatment of schizophrenia. Psychiatric Services 53:724–729, 2002LinkGoogle Scholar

3 Bridges JFP, Slawik L, Schmeding A, et al.: A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia. Health Expectations 16:164–176, 2013Crossref, MedlineGoogle Scholar

4 Woltmann EM, Wilkniss SM, Teachout A, et al.: Trial of an electronic decision support system to facilitate shared decision making in community mental health. Psychiatric Services 62:54–60, 2011LinkGoogle Scholar

5 Hibbard JH, Greene J: What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Affairs 32:207–214, 2013CrossrefGoogle Scholar

6 Matthias MS, Fukui S, Salyers MP: What factors are associated with consumer initiation of shared decision making in mental health visits? Administration and Policy in Mental Health and Mental Health Services Research 44:133–140, 2017Crossref, MedlineGoogle Scholar

7 Greene J, Hibbard JH, Sacks R, et al.: When seeing the same physician, highly activated patients have better care experiences than less activated patients. Health Affairs 32:1299–1305, 2013CrossrefGoogle Scholar

8 Salyers MP, Matthias MS, Spann CL, et al.: The role of patient activation in psychiatric visits. Psychiatric Services 60:1535–1539, 2009LinkGoogle Scholar

9 Deegan PE: The lived experience of using psychiatric medication in the recovery process and a shared decision-making program to support it. Psychiatric Rehabilitation Journal 31:62–69, 2007Crossref, MedlineGoogle Scholar

10 Pincus HA, Page AE, Druss B, et al.: Can psychiatry cross the quality chasm? Improving the quality of health care for mental and substance use conditions. American Journal of Psychiatry 164:712–719, 2007LinkGoogle Scholar

11 Mistler LA, Drake RE: Shared decision making in antipsychotic management. Journal of Psychiatric Practice 14:333–344, 2008Crossref, MedlineGoogle Scholar

12 Torrey WC, Drake RE: Practicing shared decision making in the outpatient psychiatric care of adults with severe mental illnesses: redesigning care for the future. Community Mental Health Journal 46:433–440, 2010Crossref, MedlineGoogle Scholar

13 Chewning B, Sleath B: Medication decision-making and management: a client-centered model. Social Science and Medicine 42:389–398, 1996Crossref, MedlineGoogle Scholar

14 Fortney JC, Unützer J, Wrenn G, et al.: A tipping point for measurement-based care. Psychiatric Services 68:179–188, 2016Google Scholar

15 Carpenter-Song E, Torrey WC: “I always viewed this as the real psychiatry”: provider perspectives on community psychiatry as a career of first choice. Community Mental Health Journal 51:258–266, 2015Crossref, MedlineGoogle Scholar

16 Deegan PE, Rapp C, Holter M, et al.: Best practices: a program to support shared decision making in an outpatient psychiatric medication clinic. Psychiatric Services 59:603–605, 2008LinkGoogle Scholar

17 Deegan PE: A Web application to support recovery and shared decision making in psychiatric medication clinics. Psychiatric Rehabilitation Journal 34:23–28, 2010Crossref, MedlineGoogle Scholar

18 Goscha RJ: Finding common ground: exploring the experiences of client involvement in medication decisions using a shared decision making model. Doctoral dissertation, University of Kansas, Department of Social Welfare, 2009Google Scholar

19 Hsieh H-F, Shannon SE: Three approaches to qualitative content analysis. Qualitative Health Research 15:1277–1288, 2005Crossref, MedlineGoogle Scholar

20 Lombard M, Snyder-Duch J, Bracken CC: Content analysis in mass communication: assessment and reporting of intercoder reliability. Human Communication Research 28:587–604, 2002CrossrefGoogle Scholar

21 Stata Statistical Software: Release 12 [computer program]. College Station, TX, StataCorp, LP, 2011Google Scholar

22 MacDonald-Wilson KL, Deegan PE, Hutchison SL, et al.: Integrating personal medicine into service delivery: empowering people in recovery. Psychiatric Rehabilitation Journal 36:258–263, 2013Crossref, MedlineGoogle Scholar

23 Barry MJ, Edgman-Levitan S: Shared decision making—pinnacle of patient-centered care. New England Journal of Medicine 366:780–781, 2012Crossref, MedlineGoogle Scholar